Rheumatoid athritis treatment with LLLt low level lasers.

News items, essays, documents and studies of relevant interest.

Rheumatoid athritis treatment with LLLt low level lasers.

Postby Nick Balgowan » Sun Nov 12, 2006 10:50 pm

CLINICAL APPLICATION OF GaAlAs 830 NM DIODE LASER (LLLT) IN TREATMENT OF RHEUMATOID ARTHRITIS

Kanji Aoada, Yasutaka Ytani, Akira Sakawa and Akira Shimazu - Department of Orthopaedic Surgery, Osaka City University Medical School, Japan

The authors have been involved in the treatment of rheumatoid arthritis (RA), in particular chronic poly-arthritis and the associated pain complaints. The biggest problem facing such patients is joint contracture, leading to bony ankylosis. This in turn severely restricts the range of motion (ROM) of the RA-affected Joints, thereby seriously restricting the patient's quality of life (QOL). The authors have determined that in these cases, daily rehabilitation practice is necessary to maintain the patient's QOL at a reasonable level. The greatest problem in the rehabilitation practice is the severe pain associated with RA-affected joints, which inhibits restoration of mobility and improved ROM. LLLT or low reactive level laser therapy has been recognised in the literature as having been effective in pain removal and attenuation. The authors accordingly designed a clinical trial to assess the effectiveness of LLLT in RA related pain (subjective self-assessment) and ROM improvement (objective documented data). From July 1988 to June 1990, 170 patients with a total of 411 affected joints were treated using a GaAIAs diode laser system (830 nm, 60 mW CIW). Patients mean age was 61 years, with a ratio of males: females of 1: 5.25 (16%: 84%). Effectiveness was graded under three categories: excellent (remarkable improvement?, good (clearly apparent improvement), and unchanged (little or no improvement). For, pam attenuation, scores were: excellent — 59.6%; good — 30.4%; unchanged — 10%. For ROM improvement the scores were: excellent — 12.6%; good — 43.7%; unchanged — 43.7 Yo. This gave a total effective rating for pain attenuation of 90%, and for ROM improvement of 56.3%.
Nick Balgowan.
----------------------------------------
http://www.tcgindustrial.com.au
http://www.dermaray.com
http://www.beatpsoriasis.com
----------------------------------------
User avatar
Nick Balgowan
Site Admin
 
Posts: 267
Joined: Mon Jan 09, 2006 12:29 pm
Location: Australia

Return to Media articles

Who is online

Users browsing this forum: No registered users and 11 guests

cron